{
    "title": "Biogen trims pipeline programs to cut costs, focus on Alzheimer's drug launch",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12011559/Biogen-trims-research-programs-bid-cut-costs.html",
    "date": "2023-04-25",
    "keywords": [
        "company",
        "biogen",
        "drug",
        "approval",
        "roy",
        "bhanvi",
        "satija",
        "treatment",
        "leqembi",
        "program",
        "viehbacker",
        "profit",
        "share",
        "revenue",
        "sclerosis",
        "tide",
        "inc",
        "tuesday",
        "attempt",
        "ceo",
        "progress",
        "cost",
        "executive",
        "christopher",
        "conference",
        "call",
        "companys",
        "announcement",
        "part",
        "costsaving",
        "effort",
        "hold",
        "scrap",
        "costcutting",
        "secondquarter",
        "impact",
        "forecast",
        "narrative",
        "business",
        "blair",
        "analyst",
        "marketing",
        "july",
        "depression",
        "zuranolone",
        "decision",
        "launch",
        "quarter",
        "officer",
        "michael",
        "midsingle",
        "digit",
        "tecfidera",
        "spinraza",
        "atrophy",
        "face",
        "competition",
        "couple",
        "ms",
        "term",
        "product",
        "food",
        "administration",
        "agency",
        "light",
        "qalsody",
        "form",
        "pathway",
        "access",
        "reporting",
        "bengaluru",
        "editing",
        "shinjini",
        "ganguli",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}